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Abstract 
A new, simple procedure for the determination of partition coefficients (P) was developed based on spectral effects caused upon 
addition of solutes to spin labeled model ipid membranes, and on the knowledge of their water solubility. Values of P were determined 
for nine local anesthetics (LA), amino-esters and amino-amides. The results were in good agreement with those found by phase separation 
and by a more complex, previously reported, methodology (Lissi et al. (1990) Biochim. Biophys. Acta 1021, 46-50) applied to either 
EPR or fluorescence spectra of probes incorporated in the bilayers. Both the present and the previously reported procedures make use of 
effects on membrane structure evaluated by spectroscopic techniques and offer the advantage of not requiring phase separation. The 
spectral effects, indicative of a decrease in bilayer organization i creased with LA concentration, reaching a maximum at the drug water 
solubility, indicating that partitioning in the membrane is limited by saturation of the aqueous phase. A thermodynamic analysis of the 
partition data according to Hill (Hill, M.W. (1974) Biochim. Biophys. Acta 356, 117-124) showed that the LAs did not display ideal 
behavior. Knowledge of the partition coefficients allowed a comparison between effects at the same drug concentration i  the membrane. 
Within a given family (esters, acyclic amides, cyclic amides) no clear proportionality was observed between effect and LA 
hydrophobicity, asreflected in the partition coefficient. Rather, the membrane perturbing ability is a result of steric effects originating in 
the mismatch between anesthetic and phospholipid shapes. 
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I. Introduction 
Local anesthetics (LAs) act by binding to the sodium 
channel protein, inhibiting Na + uptake and blocking the 
nervous impulse. Most local anesthetics are ionizable 
amines and both the charged and uncharged forms are 
thought o be relevant for the mechanism of anesthesia. It
has been proposed that while the uncharged form is the 
main species for transporting the anesthetic across the cell 
membrane, the protonated form binds to a specific site on 
Abbreviations: BVC, bupivacaine; CLP, chloroprocaine; DBC, dibu- 
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choline; EPC, egg phosphatidylcholine; EPR, electron paramagnetic reso- 
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the channel, triggering the anesthetic effect [1-3]. Never- 
theless, some local anesthetics are not ionizable com- 
pounds (e.g., benzocaine, benzyl alcohol) and different, as 
yet unidentified, mechanisms for blocking the sodium 
channel have been suggested for these compounds as well 
as for barbiturates, some volatile general anesthetics and 
the unprotonated form of the amines [4]. 
Structure-activity relationship studies have tried to elu- 
cidate the molecular features relevant for the action of LAs 
[5-8]. Hydrophobicity, p K a, and molecular size [5-7], and 
polar interactions [8] have been invoked as factors influ- 
encing biological effects. Amino-esters were found to be 
more potent than amino-amides. 
The lipid bilayer could be involved in the mechanism of 
anesthesia in different ways: as the medium from which 
the LA reaches the sodium channel and/or  by undergoing 
drug-induced organizational changes that would modulate 
functionally related conformational changes at the protein 
level. In addition, alterations of lipid structure are very 
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likely related to toxicity effects [9]. Therefore, it is impor- 
tant to understand the effects of anesthetics on lipid mem- 
branes. Studies designed to examine the action of LA upon 
model lipid membranes have made use of various tech- 
niques such as monolayer measurements [10,11], calorime- 
try [ 12,13], and spectroscopic methods, like UV absorption 
[ 14], fluorescence [ 15-18], infra-red [ 19,20], X-ray diffrac- 
tion [21,22], electron paramagnetic resonance [9,23-31], 
and nuclear magnetic resonance [32-41]. 
Under physiological conditions the amino-ester and 
amino-amide LAs are present in both the protonated and 
unprotonated forms. The understanding at a molecular 
level, of the events related to each species requires that 
studies be performed in systems containing only one 
species. 
In the present work, we have investigated the role of 
physicochemical and structural properties of the uncharged 
form of a series of ester (procaine, chloroprocaine and 
tetracaine) and amide (lidocaine, prilocaine, etidocaine, 
mepivacaine, bupivacaine and dibucaine) LAs (Fig. 1) on 
membrane binding and perturbation. 
Partition coefficients were determined employing EPR 
and fluorescence spectra of lipid incorporated probes. A 
novel method making use of spectral alterations due to 
anesthetic-induced bilayer disorganization, and on mea- 
sured water solubilities is presented, and the results are 
compared to those obtained by other methodologies, based 
on spectroscopic measurements and on phase separation. 
The knowledge of the partition coefficients allowed the 
comparison of the effects on bilayer structure at the same 
anesthetic concentration i  the membrane. 
2. Materials and methods 
Egg phosphatidylcholine (EPC) was extracted and puri- 
fied according to [42], as modified by Kamp et al. [43]. 
The fluorescent probe 9-PyNA was obtained from Molecu- 
lar Probes, Eugene, OR. Spin labels: 5-SASL and 5-MeSL 
came from Sigma Chemical Co., St. Louis, MO. The 
sources of LAs (in the hydrochloride form) were: TI'C: 
Sigma Chemical Co., St. Louis, MO; CLP and EDC: Astra 
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Pharmaceutical Products Inc., Westborough, MA; MVC: 
Sterling Drug Inc., Rensselaer, NY; BVC and LDC: Apsen 
Brasil, Indfistria Qufmica e FarmacSutica Ltda, S~o Paulo, 
SP; PLC: Cristfilia Produtos Qufmicos e FarmacSuticos 
Ltda, Itapira, SP; DBC: Berlimed Produtos Qufmicos, 
Farmac~uticos e Biol6gicos Ltda, Sao Paulo, SP; PRC was 
synthesized according to [44] by Dr. A.T. do Amaral, from 
the Institute of Chemistry, University of S~o Paulo. All 
other compounds were reagent grade. 
All experiments were done in 0.2 M carbonate-bi- 
carbonate buffer (pH 10.5) except for the determination of
water solubility of the charged forms of the LAs. In this 
case, 0.2 M sodium acetate buffer (pH 5.5) was used. 
Doubly distilled water was used throughout. 
Solubility determination. Aqueous LA solutions of in- 
creasing concentrations were centrifuged at 10000 × g for 
5 min at room temperature. The concentration in the 
supernatant was determined making use of the extinction 
coefficients in the UV region (Table 1). 
Membrane preparation. EPC bilayers were obtained by 
evaporating stock chloroform solutions of EPC under a 
stream of wet nitrogen. The samples were left under 
vacuum for no less than 2 h. Multilamellar liposomes were 
obtained by addition of buffer and vortexing for 5 min. 
Phospholipid concentration was determined according to 
[451. 
Spectroscopic measurements. EPC multibilayers con- 
taining 5-SASL or 5-MeSL (2% of total lipid, in moles), or 
9-PyNA (2.3-3.3%, in moles), were prepared by adding 
the proper amount of probe to the chloroform solution. 
Membrane organization was monitored by measuring 
the ratio of heights of the low-field (h+ ~ ) to the center-field 
(h 0) resonances in the EPR spectra of 5-MeSL. It has been 
previously discussed that this parameter contains the con- 
tribution of both order and mobility and is taken as ex- 
pressing changes in the overall membrane organization 
[9,26], increasing h+ i/ho values being ascribed to a less 
organized bilayer. The order parameter (S) was measured 
in the spectra of membrane-bound 5-SASL. For 5-SASL, 
whose long molecular axis is approximately parallel to the 
bilayer normal, the order parameter, S, can be obtained 
experimentally from Eq. (1): 
A l l -A~ 
s= (1) 
A==-(A,.,.+A,.~)/2 
where All(A ±) is the hyperfine splitting corresponding to
the spin label long molecular axis oriented preferentially 
parallel (perpendicular) to the external magnetic field. All 
and A± are measured as half the separation between the 
outer and the inner extrema, respectively [46]. A ...... Ass 
and A=: are the principal components of the hyperfine 
tensor and were taken as 6.0, 6.0 and 32.0 gauss [47], 
respectively. No corrections were made to account for 
differences in polarity. 
For the fluorescent probe, the intensity was monitored 
before (10) and after ( I )  addition of the anesthetic. The 
excitation and emission wavelengths were 337 and 376 
nm, respectively. Addition of LAs decreases membrane 
organization, leading to an increase in static and dynamic 
fluorescence quenching [18,30]. 
EPR spectra were obtained either in a Varian E-4 or in 
a Bruker ER-200D-SRC spectrometer at room temperature. 
Flat quartz cells came from James Scanlon, Costa Mesa, 
CA. Fluorescence spectra were obtained with a Perkin 
Elmer LS-5 spectrofluorimeter at oom temperature (22 + 
2°C). 
Partition coefficient determination by phase separation 
(Pp~). Lipid multibilayers were prepared as described 
above. A known amount of local anesthetic was added to 
EPC multibilayers, and the drug concentration remaining 
in the supernatant after centrifugation at 105 000 × g for 2 
h was determined as in the solubility experiments. The 
drug concentration i water was subtracted from the total 
drug concentration, to give the amount bound to the lipid 
phase. The partition coefficient, P, of a solute (s) between 
two phases is given by Eq. (2): 
nm(S) /Vm 
P(s) - (2) 
nw(s)/K 
where: n = number of moles of solute; V= volume; the 
subscripts m and w refer to the membrane and aqueous 
phase, respectively. 
P determination by spectroscopic methods. P was de- 
termined from EPR (Pepr) and fluorescence (Pnuor) experi- 
ments, making use of the methodology described by Lissi 
et al. [30]. Briefly, the method consists in assuming that a 
given effect on membrane structure is proportional to the 
amount of solute bound to the membrane. Experiments are 
done by adding increasing amounts of solute to a given 
membrane concentration. Then, a family of plots of effect 
vs. total number of moles of solute, n t (n  t = n w + rim), is 
obtained for various membrane concentrations. The same 
effect in each plot represents the same solute:lipid molar 
ratio, in the membrane. Plots of n t vs. membrane volume 
for the same effect yield a straight line described by Eq. 
(3): 
f ro (S )  " V,~, 
nt (s  ) -- n t- Cm(S ) " V m (3)  P(s) 
where Cm(s) is the solute concentration i the membrane, 
and corresponds to nm/V m in Eq. (2). The partition coeffi- 
cient can be obtained from Eq. (3a): 
slope 
P(s) = . -V~, (3a) 
intercept 
P was also determined by a novel procedure, based on 
the measurement of the concentration of LA necessary to 
cause the maximum membrane perturbation (Em, ~, as 
monitored by spin label EPR spectra) and on its water 
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solubility (see Results). P values calculated by this proce- 
dure are represented by P, ol- 
3. Resu l ts  
The pK a values of the LAs in aqueous medium vary 
between 7.6 and 9.2 [7,48,49]. It has been shown that the 
apparent pK of positively charged compounds decreases in 
the presence of zwitterionic membranes [26,50-52]. There- 
fore, in the present experiments, performed at pH 10.5, the 
drugs are essentially in the uncharged form. 
Table I shows the optical absorption properties of the 
LAs in the UV region and the water solubility of the 
charged and uncharged forms. Clearly, the protonated form 
is more soluble by two or three orders of magnitude. 
Addition of the uncharged LA to EPC membranes led 
to a change in bilayer organization. An increase in the 
empirical parameter h+l /h  o was calculated from the EPR 
spectra of 5-MeSL, as well as a decrease in the order 
parameter from the spectra of 5-SASL. Previous work has 
shown that uncharged PRC and TTC have a larger effect 
on bilayer structure than their protonated counterparts 
[26,32]. 
Spectra of 5-MeSL indicated that the decrease in bilayer 
organization is a function of LA concentration, a maxi- 
mum effect (Ema x) being reached at different concentra- 
tions for the different LAs. Beyond Ema x, the ester and 
amide anesthetics displayed different behavior: while the 
amides led to constant h+~/h o (Fig. 2), ester anesthetics 
yielded decreasing h+l /h  o values (Fig. 3). 
Since the neutral forms of the LAs have a limited water 
solubility (Table 1), under the conditions of the experi- 
ment, eventually an aqueous concentration is reached that 
corresponds to this solubility. At this point, since the 
aqueous phase becomes aturated with the anesthetic, no 
more drug partitions into the membrane. This explains the 
constant maximum effect observed in the case of the 
amide anesthetics. The more complex behavior of h + ~/h o 
for the esters was previously reported for TTC and was 
ascribed to the appearance of a second, anesthetic-en- 
riched, lipid phase [9]. Partitioning of the probe into this 
phase leads to the appearance of an additional spectral 
component, causing the decrease of h+j /h  o at the higher 
drug concentrations (Fig. 3). Fig. 4 illustrates the spectral 
effects for CLP. Initially, the drug causes an increase in 
h+]/h  o values (Fig. 4B). At higher CLP concentration a 
more immobilized spectral component is observed (Fig. 
4C). Also in these cases Ema x occurs at the anesthetic 
solubility in water. 
The breaks in the plots of spectral parameters vs. LA 
concentration such as those in Figs. 2 and 3 can be used to 
calculate the drug membrane-water partition coefficient. 
As mentioned above, the breakpoints occur at the drug 
solubility in water, S w. This means that n w in Eq. (2) is 
known. Since the total number of drug molecules (n t) is 
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Fig. 2. Effect of LDC concentration  the h+l /h  o ratio for spectra of 
5-MeSL in EPC multilamellar vesicles, n t represents he number of 
moles of LDC in 1.0 ml of aqueous phase (Vw). [EPC]= 2 mM, 0.2 M 
carbonate/bicarbonate buffer (pH 10.5), 22°C. Effect (%)= 
100((h+ I / h0)sample -(h+ I /ho )cont ro l ) / ( (h+l  / h0)control)" 
also known, it is possible to derive n m and, therefore, P 
(P~ol)- In spite of the more complex behavior of the ester 
anesthetics, the procedure is also applicable to these com- 
pounds. 
The values of P~ot calculated from the above analysis 
are presented in Table 2. These values are compared to 
those determined by phase separation (Pp~) and by the 
procedure described by Lissi et al. [30], making use of 
both EPR (Pepr) and fluorescence measurements (Pfluor). It 
is seen that the agreement between the values obtained by 
the various procedures is very good. In particular, the 
values of P~ol are in close agreement with those found by 
phase separation. Thus, the knowledge of the drug aqueous 
solubility enables one to use a very simple procedure to 
evaluate P without requiring phase separation. It is also 
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Fig. 3. Effect of the ester LAs concentration  the h+l /h  o ratio for 
spectra of 5-MeSL in EPC multilamellar vesicles: PRC ([]), TTC (zx) 
and CLP (©). [EPC] = 20 mM, n t represents the number of moles of LA 
in 1.0 ml of aqueous phase (Vw), 0.2 M carbonate/bicarbonate buffer 
(pH 10.5), 22°C. 
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Table 1 
Wavelength of maximum absorption (Ama x), molar extinction coefficient (e), and aqueous olubility (S w ) of the local anesthetics at22°C 
29 
LA Charged LA a Uncharged LA b 
Area x ,~ S w Area x ~ S w 
(nm) (M- I cm- I ) (/zM) (nm) (M I cm- I) (mM) 
PRC 290 16 500 2.95 287 15 000 16.3 
CLP 290 25 000 0.20 287 23 000 1.98 
TTC 310 21 800 1.34 307 24 900 0.76 
LDC 263 480 2.30 262 420 13.1 
PLC 265 280 0.83 270 850 23.1 
EDC 263 480 0.20 262 420 0.16 
MVC 263 550 1.30 263 440 8.82 
BVC 263 470 0.07 263 600 0.58 
DBC 327 43 000 1.90 327 38 000 0.03 
a 0.2 M sodium acetate buffer (pH 5.5). b 0.2 M carbonate/bicarbonate buffer (pH 10.5). 
more advantageous over  the methodology previously de- 
scribed [30], since it does not require working with differ- 
ent membrane concentrations. 
Studies were also performed with the spin label 5-SASL.  
The results for LDC and PLC are in agreement with those 
found with 5-MeSL:  a decrease in order parameter upon 
addition of  LA  is observed, fo l lowed by a plateau for 
higher concentrations (Fig. 5). The breakpoints in these 
plots yield P,~ol values for LDC and PLC (Table 2) in good 
agreement with the values found with 5-MeSL.  
High LA /phospho l ip id  molar ratios (Table 3, see be- 
low) can be reached at the max imum effect. One might 
expect that such ratios would cause changes in partition 
coeff ic ient and, eventually, micel l ization of  the bilayer. In 
(B) _.~ 
Fig. 4. EPR spectra of 5-MeSL in EPC multibilayers in the absence (A) 
and in the presence of 10 mM (B) and 40 mM (C) CLP. The arrow 
indicates the low field resonance of the less mobile spectral component 
that appears at high CLP concentration. [EPC] = 20 mM, 0.2 M carbon- 
ate/bicarbonate buffer (pH 10.5), 22°C. 
fact, Abuin and Lissi [53] have found changes in the 
partitioning of  alcohols into micel les as the alcohol con- 
centration increased. Bi layer micel l ization has been found 
in the presence of  high concentration of cationic TTC 
[9,54] and of uncharged analogs of  T rc  [55]. Nevertheless, 
within the accuracy of  our experiments, no significant 
deviation of  l inearity was detected in plots of  spectral 
parameters vs. LA concentration, which would be sugges- 
tive of  changes in P. Moreover,  under no circumstances 
did the spin probe spectra provide any indication of  anes- 
thetic- induced micell ization. 
A quantititative valuation of  the LA-b i layer  interac- 
tion was done making use of  the LA  water solubility and 
of  spectral effects. Table 3 displays several parameters 
calculated by this approach. Values of  Ema x for the various 
anesthetics are shown, together with the values of  n t 
needed to reach Ema x for a given membrane concentration 
(16.7 mM EPC). The experimental ly obtained values of 
Table 2 
Partition coefficients for the 
layers at pH 10.5 a.b 
uncharged forms of the LAs in EPC multibi- 
LA Pp~ Pepr etluor Psol c Pps "Sw e 
PRC 84+ 32 96 228 72 1.05 
CLP 250+ 46 134 396 258 0.38 
T'['C 868 + 23 780 980 697 0.51 
LDC 144+ 54 127 223 92; 130 d 1.45 
PLC 110+ 61 134 305 96; 86 d 1.96 
EDC 1202+480 - 1251 1077 0.15 
MVC 98-1- 12 246 245 75 0.67 
BVC 798+147 - 1168 870 0.36 
DBC 2240+ 1050 - - 8280 0.051; 0.191 f
a Definitions of Pp~, Pepr, Pfluor and P~ol and experimental conditions are 
given in Materials and methods, b pp~ values are the average of four 
experiments; Pepr, Pnuor and P~ol are the average of two experiments. 
c From 5-MeSL spectra (see text), d From 5-SASL spectra, eCalculated 
taking the concentrations a mole solute/mole solvent, f Calculated using 
Pso] • 
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Fig. 5. Effect of LDC (O) and PLC (+) concentration the order 
parameter of 5-SASL in EPC multilamellar vesicles. [EPC] = 18 mM, n t 
represents the number of moles of LA in 1.0 ml of aqueous phase (V~), 
0.2 M carbonate/bicarbonate buff r (pH 10.5), 22°C. 
of moles of LA in the membrane, at Ernax , obtained from 
Eq. (5): 
n (s) 
//m(S) -- i (5) 
1 +Sw' - -  
Vm 
The values of n m are shown as LA/EPC molar ratios at 
the maximum effect (fifth column) in Table 3. 
As shown in Table 3, both Ema x and the LA:lipid molar 
ratio at Ema x are different for the different anesthetics. 
Clearly, it is desirable to compare the structural effects 
caused by the different LAs at the same concentration i  
the membrane. This was accomplished making use of Eq. 
(5) and plots of effect vs. n t. The effects at LA/EPC (1:3, 
mole/mole) are given in Table 3. For EDC and DBC, the 
limiting membrane concentration is reached at LA/EPC 
molar ratios smaller than 1:3. For the sake of comparison, 
these values were obtained by extrapolation. Except for the 
smaller effects found for PRC (3.8%) and for the cyclic 
amides MVC (6.6%) and BVC (5.4%) all other anesthetics 
displayed effects ranging from 9.2 to 15.9%. 
4. D iscuss ion  
nt max were compared to values calculated from the parti- 
tion coefficients measured by phase separation, and from 
the drug solubility in water, according to Eq. (4): 
ntmax(S ) = W m " Pps(S) + Sw(S ) (4 )  
Except for DBC, whose water solubility is very low, the 
agreement between experimental nd calculated values is 
very good. The table also shows n . . . . .  i.e., the number 
The present results report on qualitative and quantitative 
aspects of local anesthetics-lipid bilayer interaction. The 
effects of the uncharged forms of three ester and six amide 
anesthetics upon the organizational properties of egg phos- 
phatidylcholine multibilayers were examined making use 
of EPR spin label spectroscopy. EPR and fluorescence data 
were utilized to calculate partition coefficients, in the line 
of previous work from this laboratory [30,31]. 
Table 3 
Quantitative comparison of the effect ~ of the LAs upon EPC multibilay- 
ers h derived from EPR data 
LA Emax a nt max c nt max d LA/EPC Effect for 
(expt.) (calc.) at LA/EPC 1:3 
(/xmoles) (/zmoles) Ema x (mole/mole) 
PRC 17.0 31.5 34.0 2.7:3 3.76 
CLP 15.0 8.60 8.35 1.2:3 12.1 
TTC 15.0 9.38 9.28 1.5:3 13.9 
LDC 26.5 28.6 37.4 2.8:3 10.4 
PLC 13.0 51.7 56.0 5.1:3 9.22 
EDC 7.5 2.21 2.67 0.4:3 15.9 ~ 
MVC 10.5 16.5 20.0 1.4:3 6.64 
BVC 7.8 7.75 6.56 1.3:3 5.38 
DBC 8.2 3.56 0.90 0.6:3 13.3 c 
Effect is defined in the caption of Fig. 2, Ema x is the maximum effect 
achieved, b In this experiment [EPC] = 16 mM; experimental conditions 
are described in Materials and methods, c Total number of moles of LA 
in 1.0 ml aqueous phase necessary for the observation of Ema x. d Total 
number of moles of LA in 1.0 ml aqueous phase necessary to obtain 
Ema X , calculated from Eq. (4). ~ The maximum concentration f LA in the 
membrane occurs at an LA/EPC ratio smaller than 1:3 (see text). 
4.1. Determination and thermodynamic analysis of parti- 
tion coefficients 
We have previously presented a methodology making 
use of spectroscopic measurements for the determination 
of membrane-water partition coefficients without the re- 
quirement of phase-separation [30]. The formalism devel- 
oped can be applied to any measurement providing infor- 
mation about concentration-dependent effects of partition- 
ing solutes upon membrane properties. The elimination of 
the phase separation step avoids errors due to eventual 
solute co-sedimentation [56] as well as membrane remain- 
ing in the supernatant. Moreover, problems due to time-de- 
pendent processes, such as chemical reactions involving 
the solute (or the membrane) are also largely circum- 
vented. The methodology described by Lissi et al. [30] is 
based on the addition of increasing solute concentrations to 
a family of fixed membrane concentrations. 
In this paper we show that an even simpler procedure 
can be used to evaluate P, as long as the drug water 
solubility is known, and is sufficiently low to reach water 
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saturation under the conditions of the experiment. Thus, 
we found that the disorganizing effect of the LAs upon the 
bilayer structure increases with LA concentration, reaching 
a maximum (Emax). While Ema x remains constant for the 
amide series upon further drug addition ( Figs. 2 and 5), a 
decrease is observed for the ester series (Fig. 3). Ema x was 
found to occur at the drug water solubility, S w. Since P is 
a thermodynamic constant; once the aqueous phase be- 
comes saturated, no more solute can partition into the 
membrane. A similar effect was found by Hill for n-al- 
cohols and general anesthetics, in dipalmitoylphosphatidyl- 
choline (DPPC) bilayers [57]. In addition, Pringle et al. 
observed that the anesthetic potency of n-alcohols upon 
murine neurons increased with the acyl chain length, up to 
12 carbons. Then, a cut-off effect occurred, longer n-al- 
cohols (whose S w < 10 6 M) having either the same effect 
as shorter ones, or none [58]. 
In a study of the binding of hexachlorocyclohexane 
insecticides to dioleoylphosphatidylcholine bilayers, Jones 
and Lee also found that the binding was limited by satura- 
tion of the aqueous rather than the lipid phase, and that the 
maximum concentration reached in the lipid does not 
correspond to saturation of available binding sites [59]. 
Holland and Schreier found a similar behavior for the 
antichagasic drug nifurtimox in DPPC bilayers (unpub- 
lished results). 
As shown in Results, the knowledge of S w and the total 
drug concentration (n t max ) to reach Ema x for a given 
membrane concentration allows the calculation of the par- 
tition coefficient (P,o~). In Table 2 the values of P calcu- 
lated by this procedure are compared to those found by 
phase separation and by the Lissi et al. methodology [30] 
from EPR and fluorescence measurements ( Pps, Pepr, Pn . . . .  
respectively). It is seen that all values are in reasonable 
agreement, and that the values of P~o~ are the closest to 
Pp~. 
Hill [57] has described a thermodynamic analysis of the 
partition coefficient and derived the equation: 
P .S  w =2 (6) 
(concentrations in mole solute/mole solvent), for the ideal 
case. While the author found that this product was ob- 
served for even-numbered, but not for odd-numbered chain 
length alcohols, Lee [60] found that the product decreased 
as a function of chain length. 
Table 2 shows that in the case of the LAs, the P • S w 
product is far from 2 in most cases, indicating that parti- 
tioning is non-ideal. Values of P .  S w < 2 were also ob- 
tained for inhalation anesthetics [57] and hexachlorocyclo- 
hexanes [59]. In the present study, values closer to 2 were 
obtained for the more water-soluble anesthetics (LDC, 
1.45, and PLC, 1.96). A larger deviation for the less 
soluble compounds was also found in the n-alcohol series 
([60] and [61], as pointed out in ref. [60]). 
The lack of ideal behavior has been ascribed to incom- 
plete exclusion of solute from the gel phase and non-ideal 
mixing between solute and phospholipid [ 14,62-64]. 
4.2. Structure-activity analysis of the LAs effects on mem- 
brane organization 
The spin label spectra indicated that addition of the LA 
causes a decrease of overall organization (h+l /h  o, 5- 
MeSL) and of the degree of bilayer order (S, 5-SASL). 
The results are in agreement with those obtained from 
deuterium NMR data that revealed both structural (de- 
crease of quadrupole splittings) and dynamical (increase of 
relaxation times) effects of the LAs on phospholipid mem- 
branes (de Paula, E., Jarrell, H.C. and Schreier, S., in 
preparation). 
A quantitative analysis was made by calculating the 
amount of membrane bound drug from P values. Table 3 
shows that the LA/EPC molar ratio at Ema x varies by a 
factor of ca. 10, being smaller for the less water soluble 
compounds. This is one more indication that the amount of 
drug bound to the membrane is restricted by its water 
solubility, and is a consequence of the fact that P in- 
creases less rapidly than the solubility decreases. 
The effects of local anesthetics have been analysed in 
terms of structure-activity relationships. Several phar- 
macological effects have been interpreted as being the 
result of various factors: drug hydrophobicity, as measured 
by the partition coefficient, pK~ (extent of ionization in 
aqueous medium), and molecular size [5-7], as well as 
polar interactions [8]. The ionization degree is not dealt 
with in the present work, since it focuses only on the 
uncharged form of the LAs. In a previous study [26], we 
have analysed the effect of membrane binding on the 
extent of drug ionization, taking into account that it is 
affected by the differences in partition coefficient between 
the protonated and unprotonated forms, i.e., ApK= 
pKmemb .... --pKwate r is proportional to Ap  (Puncharged- 
Pch,rged) [26,50--52]. In summary, both forms bind to the 
lipid bilayer, and their molar ratio is not the same as that in 
water at a given pH. As for the role of hydrophobicity, it 
has been found that several pharmacological effects are 
proportional to the partition coefficient, within a family of 
related structure [5-7,49]. Thus, the ester anesthetics were 
seen to be more active than the amides. In some analysis, 
the cyclic amides were found to be less active than the 
acyclic analogues [5,7]. The differences between families 
have been ascribed to molecular size. The latter contribu- 
tion has been analysed in detail in terms of different parts 
of the molecule: the bulkiness of the aromatic methyl 
groups, the orientation of the ester vs. the amide bond, and 
the branched vs. cyclic amide portion in the amino-amides 
[6]. 
The present results do not reveal a clear proportionality 
between P and effect on membrane organization within a 
given family of LAs, when compared at the same concen- 
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tration in the bilayer (Table 3). This is not unexpected, 
since membrane perturbation should be related to steric 
effects. 
Balgav~ and co-workers [65] have proposed that the 
differences in free volume generated by the mismatch 
between the shapes of the anesthetic and the phospholipid 
could be responsible for the different structural effects. In 
fact, a comparison between PRC (from the amino-ester 
series) and LDC and PLC (from the amino-amide series), 
whose partition coefficients are quite similar, shows that 
the latter exert a much larger membrane perturbing effect. 
PLC and LDC posses one to two -CH 3 groups in the 
aromatic ring, respectively, and very branched aliphatic 
portions. The hydrophobic volume of a methyl group is 
quite large, and would give rise to a large free volume. 
This might be a prevalent factor in the PLC, LDC, EDC 
series, leading to a smaller ange of effects (9-16%) than 
in the ester series (3-13%), where the chlorine atom of 
CLP and the straight N-butyl chain of TTC are responsible 
for the differences with respect to PRC. The smaller 
effects observed for MVC and BVC might be due to 
replacement of the branched side chains by the cyclic 
amine moiety, leading to a decrease in the free volume. 
Here, again, essentially no difference is seen between 
MVC (P  ~- 100) and BVC (P  ~ 800). We are tempted to 
speculate that the greater hydrophobic haracter of the 
cyclic amine portion might facilitate its insertion (upside- 
down) in the bilayer, thereby decreasing the steric pertur- 
bation. 
It is also conceivable that the different effects might be, 
in part, associated with different membrane location of the 
LAs. Indeed, NMR data has indicated that PRC is located 
more superficially than TTC [32] and that charged TTC is 
located closer to the aqueous interface than its uncharged 
counterpart [33]. The interactions between the LAs and 
phospholipids can be of hydrophobic, as well as polar 
nature. The balance between them will determine the 
preferential membrane location. Work is under way to 
examine this possibility. 
It has been proposed that the lesser biological activity 
of the amide anesthetics i  due to the more difficult fitting 
in a specific site at the sodium channel due to steric 
hindrance [6]. Interestingly, the differences found in the 
present work at the lipid bilayer level seem to be of the 
same nature. 
In conclusion, we have shown that spin label spectra in 
conjunction with the knowledge of water solubility allows 
the determination f membrane-water partition coefficients 
through a very simple procedure that does not require 
phase separation. The values thus obtained are in very 
good agreement with those obtained by classical proce- 
dures, and by other methodologies employing spectro- 
scopic measurements. The work has also allowed the 
comparison of the effects of different LAs on membrane 
organization at the same concentration i  the membrane. It 
was found that differences between the LA are a function 
of steric effects due to the mismatch between anesthetic 
and phospholipid shapes. The possibility of different mem- 
brane location will be further investigated. 
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